| [1] |
Heneka MT, Kummer MP, Latz E. Innate immune activation in neurodegenerative disease[J]. Nat Rev Immunol, 2014, 14(7):463-477.
|
| [2] |
Ricklin D, Lambris JD. Complement in immune and inflammatory disorders: pathophysiological mechanisms[J]. J Immunol, 2013, 190(8):3831-3838.
|
| [3] |
Orsini F, De Blasio D, Zangari R, et al. Versatility of the complement system in neuroinflammation, neurodegeneration and brain homeostasis[J]. Front Cell Neurosci, 2014, 8:380.
|
| [4] |
Canova C, Neal JW, Gasque P. Expression of innate immune complement regulators on brain epithelial cells during human bacterial meningitis[J]. J Neuroinflammation, 2006, 3(1):22.
|
| [5] |
Bellander BM, Singhrao SK, Ohlsson M, et al. Complement activation in the human brain after traumatic head injury[J]. J Neurotrauma, 2001, 18(12):1295-1311.
|
| [6] |
高谋，徐如祥，王海峰,等.诱导型神经干细胞对颅脑创伤后免疫细胞的影响[J].中华神经创伤外科电子杂志, 2017, 3(6):355-359.
|
| [7] |
Gao M, Dong Q, Yao H, et al. Induced neural stem cells modulate microglia activation states via CXCL12/CXCR4 signaling[J]. Brain Behav Immun, 2017, 59(1):288-299.
|
| [8] |
Simon DW, McGeachy MJ, Bayir H, et al. The far-reaching scope of neuroinflammation after traumatic brain injury[J]. Nat Rev Neurol, 2017, 13(3):171-191.
|
| [9] |
Carney N, Totten AM, O'reilly C, et al. Guidelines for the management of severe traumatic brain injury[J]. Neurosurgery, 2017, 80(1):6-15.
|
| [10] |
Holers VM. Complement and its receptors: new insights into human disease[J]. Annu Rev Immunol, 2014, 32(1):433-459.
|
| [11] |
Amor S, Peferoen LA, Vogel DY, et al. Inflammation in neurodegenerative diseases--an update[J]. Immunology, 2014, 142(2):151-166.
|
| [12] |
Morgan BP, Harris CL. Complement, a target for therapy in inflammatory and degenerative diseases[J]. Nat Rev Drug Discov, 2015, 14(12):857-877.
|
| [13] |
Hammad A, Westacott L, Zaben M. The role of the complement system in traumatic brain injury: a review[J]. J Neuroinflammation, 2018, 15(1):24.
|
| [14] |
Brennan FH, Anderson AJ, Taylor SM, et al. Complement activation in the injured central nervous system: another dual-edged sword[J]. J Neuroinflammation, 2012, 9(1):137-142.
|
| [15] |
Stephan AH, Barres BA, Stevens B. The complement system: an unexpected role in synaptic pruning during development and disease[J]. Annu Rev Neurosci, 2012, 35(1):369-389.
|
| [16] |
Moriyama M, Fukuhara T, Britschgi M, et al. Complement receptor 2 is expressed in neural progenitor cells and regulates adult hippocampal neurogenesis[J]. J Neurosci, 2011, 31(11):3981-3989.
|
| [17] |
Kim H, Mizuno M, Furuhashi K, et al. Rat adipose tissue-derived stem cells attenuate peritoneal injuries in rat zymosan-induced peritonitis accompanied by complement activation[J]. Cytotherapy, 2014, 16(3):357-368.
|
| [18] |
Rancan M, Morganti-kossmann MC, Barnum SR, et al. Central nervous system-targeted complement inhibition mediates neuroprotection after closed head injury in transgenic mice[J]. J Cereb Blood Flow Metab, 2003, 23(9):1070-1074.
|
| [19] |
Leinhase I, Schmidt OI, Thurman JM, et al. Pharmacological complement inhibition at the C3 convertase level promotes neuronal survival, neuroprotective intracerebral gene expression, and neurological outcome after traumatic brain injury[J]. Exp Neurol, 2006, 199(2):454-464.
|
| [20] |
Pedersen ED, Løberg EM, Vege E, et al. In situ deposition of complement in human acute brain ischaemia[J]. Scand J Immunol, 2009, 69(6):555-562.
|
| [21] |
Miwa T, Zhou L, Hilliard B, et al. Crry, but not CD59 and DAF, is indispensable for murine erythrocyte protection in vivo from spontaneous complement attack[J]. Blood, 2002, 99(10):3707-3716.
|
| [22] |
Caragine TA, Imai M, Frey AB, et al. Expression of rat complement control protein Crry on tumor cells inhibits rat natural killer cell-mediated cytotoxicity[J]. Blood, 2002, 100(9):3304-3310.
|